3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
7
Leukemia, Myeloid, Acute
5
Neuroblastoma
2
Neoplasm Metastasis
2
Thyroid Neoplasms
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Melanoma
1
Hepatoblastoma
1
Gastrointestinal Stromal Tumors
1
Fibrolamellar hepatocellular carcinoma
1
Interventions
Specimen Handling
6
pembrolizumab
4
enfortumab vedotin
4
Magnetic Resonance Spectroscopy
4
Gemcitabine
3
cabozantinib
2
Nivolumab
2
Carboplatin
2
Biopsy
2
relatlimab
1
eribulin
1
erdafitinib
1
avelumab
1
atezolizumab
1
Watchful Waiting
1
Standard of Care
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Plasma Exchange
1
Observation
1
Lenalidomide
1
Ipilimumab
1
Doxorubicin
1
Cystoscopy
1
Contrast Media
1
Cisplatin
1
Central Venous Catheters
1
CTLA-4 Antigen
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Sorafenib
×
90 days
×
Clear all
No trials found.